2026 NPPES data Ophthalmology Physician NPI 1710959549 M.D.
Verify on CMS →

JOHN ROSENTHAL, M.D.

Ophthalmology Physician in MAUMEE, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
772
Medicare Part D claims · 252 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

JOHN ROSENTHAL, M.D. filed 772 Medicare Part D claims in 2023 as a Ophthalmology Physician in MAUMEE, Ohio, prescribing 61% generic.

772
Part D claims, 2023
61%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN ROSENTHAL, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

772 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOHN ROSENTHAL, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN ROSENTHAL, M.D.?

Quality data not reported

NPI registry status

Active

Issued 02/06/2006

NPI 1710959549

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

772 46% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Ohio

How Ophthalmology Physician compares to other specialties among Ohio providers

Ohio providers

Ophthalmology Physician share within Ohio

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Ohio

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN ROSENTHAL, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 5757 MONCLOVA RD STE 11, MAUMEE, OH, 43537, with a listed phone of (419) 873-6800. NPI 1710959549 was issued on 02/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROSENTHAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 772 prescription claims written by this provider, covering 252 Medicare beneficiaries and totaling roughly $31K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5757 MONCLOVA RD STE 11
MAUMEE, OH 43537

Provider Details

NPI 1710959549
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 02/06/2006

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to JOHN ROSENTHAL, M.D.. To verify JOHN ROSENTHAL, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JOHN ROSENTHAL, M.D. — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 772 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

772
Total Claims
$31K
Total Drug Cost
252
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,028
Total Day Supply
27,768
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$21K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
1.79
Gender Split
53% female / 47% male
Age Distribution
<65: 39, 65-74: 101, 75-84: 79, 85+: 33

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOHN ROSENTHAL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
154
Ciprofloxacin Hcl
123
Ketorolac Tromethamine
115
Brimonidine Tartrate
88
Latanoprost
68
Timolol Maleate
56
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
28
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
25
Dorzolamide Hcl
20
Erythromycin
Erythromycin Base
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How JOHN ROSENTHAL, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

JOHN ROSENTHAL, M.D.'s 772 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as ROSENTHAL.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN ROSENTHAL, M.D.'s specialty?
JOHN ROSENTHAL, M.D. specializes in Ophthalmology Physician and practices in MAUMEE, Ohio. Credentials: M.D..
How much does JOHN ROSENTHAL, M.D. prescribe under Medicare Part D?
In 2023, JOHN ROSENTHAL, M.D. wrote 772 Medicare Part D claims totaling $31K in drug costs for 252 beneficiaries.
Where is JOHN ROSENTHAL, M.D. located?
JOHN ROSENTHAL, M.D. is located at 5757 MONCLOVA RD STE 11, MAUMEE, OH, 43537. Phone: (419) 873-6800.
What is JOHN ROSENTHAL, M.D.'s NPI number?
JOHN ROSENTHAL, M.D.'s National Provider Identifier (NPI) is 1710959549, issued on 02/06/2006.
Does JOHN ROSENTHAL, M.D. prescribe more brand-name or generic drugs?
JOHN ROSENTHAL, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $21K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does JOHN ROSENTHAL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN ROSENTHAL, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Ciprofloxacin Hcl, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN ROSENTHAL, M.D. accept Medicare?
JOHN ROSENTHAL, M.D. appears in CMS Medicare data with 772 Part D claims and 252 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN ROSENTHAL, M.D.'s credentials?
JOHN ROSENTHAL, M.D.'s NPI is 1710959549 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology